Physician profile
Bret Gerstner
NPI 1972064285
$631.02
in general payments reported to CMS, 2019-2025
13 companies · $387 in 2025
The $387 reported for 2025 was more than what 75% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $90.04 · 2024: $154 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $167.79 | 2025 | Alphavent |
| Vertex Pharmaceuticals Incorporated | $121.49 | 2024-2025 | |
| Elite Orthopedics, LLC | $103.37 | 2023-2025 | |
| Abbvie INC. | $41.21 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $39.11 | 2023-2025 | Exparel, Zilretta, Iovera |
| Zimmer Biomet Holdings, INC. | $34.65 | 2023-2024 | Persona, Identity, Tapestry |
| Avanos Medical | $24.33 | 2024 | On-Q* Pump and Accessories |
| Janssen Biotech, INC. | $20.03 | 2025 | Tremfya |
| Orthalign INC | $19.50 | 2025 | Orthalign Plus |
| Orthofix Medical, INC. | $16.46 | 2025 | Cervical-Stim |
| Antares Pharma, INC. | $15.31 | 2024 | Xyosted |
| Lundbeck LLC | $14.67 | 2024 | Vyepti |
| Phathom Pharmaceuticals, INC. | $13.10 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Gerstner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.